BlueBrainBoost
freedom-pharmacy
Purchases through the above links give commission which helps fund this website
Recent literature: Dipeptidyl peptidase 4 inhibitor
Date Journal Article title
2019 Nov Arch Pharm (Weinheim) Benzo[4,5]thieno[2,3-d]pyrimidine phthalimide derivative, one of the rare noncompetitive inhibitors of dipeptidyl peptidase-4.
2019 Oct Diabetes Metab J Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice.
2019 Diabetol Metab Syndr Treatment patterns of drug-naive patients with type 2 diabetes mellitus: a retrospective cohort study using a Japanese hospital database.
2019 Nov J Invest Surg Dipeptidyl peptidase-4 (DPP-4) inhibitor saxagliptin alleviates lipopolysaccharide-induced acute lung injury via regulating the Nrf-2HO-1 and NF-biκibB pathways.
2019 Nov Diabetes Obes Metab Role of endogenous glucagon-like peptide-1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetes.
2019 Nov Diabet Med Intensive monitoring of adverse drug events associated with the use of new glucose-lowering drugs: results from an inception cohort study in Portugal.
2019 Nov Expert Opin Pharmacother Safety and efficacy of vildagliptin: 52-week post-marketing surveillance of Japanese patients with type 2 diabetes in combination with other oral antidiabetics and insulin.
2019 Int J Nanomedicine Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo.
2019 Oct Eur J Med Chem Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents.
2019 Korean J Physiol Pharmacol Efficacy of evogliptin and cenicriviroc against nonalcoholic steatohepatitis in mice: a comparative study.
2019 Oct Toxicol Appl Pharmacol Dipeptidyl peptidase-4 inhibitor sitagliptin induces vasorelaxation via the activation of Kv channels and PKA.
2019 Nov Diabetes Ther Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial.
2019 Oct Diabetes Res Clin Pract Effects of anagliptin on plasma glucagon levels and gastric emptying in patients with type 2 diabetes: an exploratory randomized controlled trial versus metformin.
2019 Oct BMC Cancer Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
2019 Oct Molecules New Molecular Insights into the Inhibition of Dipeptidyl Peptidase-4 by Natural Cyclic Peptide Oxytocin.
2019 Oct Biomed Chromatogr Development of a liquid chromatographytandem-mass spectrometry assay for the simultaneous determination of teneligliptin and its active metabolite teneligliptin sulfoxide in human plasma.
2019 Oct Drug Saf Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus.
2019 Oct J Dermatol Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.
2012 LiverTox: Clinical and Re... Saxagliptin
2012 LiverTox: Clinical and Re... Linagliptin
2012 LiverTox: Clinical and Re... Alogliptin
2012 LiverTox: Clinical and Re... Sitagliptin
2019 Oct Bioorg Chem Optimization of the benzamide fragment targeting the S2' site leads to potent dipeptidyl peptidase-IV inhibitors.
2019 Oct Intern Med DPP-4 Inhibitor-associated Bullous Pemphigoid in a Hemodialysis Patient.
2019 Oct Diabetes Ther Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease.
2019 Oct Biofactors Sitagliptin protects liver against aflatoxin B1-induced hepatotoxicity through upregulating Nrf2AREHO-1 pathway.
2019 Oct QJM Dipeptidyl Peptidase-4 Inhibitor Treatment Could Decrease Chronic Rhinosinusitis in Diabetic Patients.
2019 Eur J Case Rep Intern Med Linagliptin-Associated Alopecia and Bullous Pemphigoid.
2019 Oct Pediatr Surg Int DPP4 inhibitor reinforces cell junction proteins in mouse model of short bowel syndrome.
2019 J Assoc Physicians India A ProspectIve, OpeN-Label, Randomized Study Comparing EffIcacy and Safety of Teneligliptin VErsus Sitagliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: INSITES Study.
2019 Sep BMJ Case Rep Linagliptin-associated bullous pemphigoid treated with rituximab.
2019 Sep Cells TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats.
2019 Ther Adv Chronic Dis The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from iin silicoi to iin vivoi.
2019 Sep J Dairy Sci Bioactivity of hydrolysates obtained from bovine casein using artichoke (Cynara scolymus L.) proteases.
2019 BMJ Open Diabetes Res Care Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.
2019 Sep Diabet Med Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.
2019 Sep JAMA Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
2019 J Postgrad Med Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor - A case report.
2019 Oct J Endocr Soc Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition.
2019 Sep Diabetes Res Clin Pract Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study.
2019 Aug World J Diabetes Development of therapeutic options on type 2 diabetes in years: Glucagon-like peptide-1 receptor agonist's role intreatment; from the past to future.
2019 J Clin Med Res Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus.
2019 Sep Diabetes Obes Metab Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study).
2019 Sep Mod Rheumatol Clinical analysis of pre-existing diabetes mellitus and dipeptidyl peptidase-4 inhibitors in patients with remitting seronegative symmetrical synovitis and pitting edema syndrome.
2019 Sep Br J Dermatol Clinical and immunological characterisation of 14 cases of dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid: a single centre study.
2019 Korean J Physiol Pharmacol Effect of gemigliptin on cardiac ischemiareperfusion and spontaneous hypertensive rat models.
2019 Cancer Manag Res Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus.
2019 Diabetes Metab Syndr Obes Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a dbdb mouse model of type 2 diabetes: a comparison with the effect of glimepiride.
2019 Physiol Rep Dipeptidyl peptidase-4 inhibitors and aerobic exercise synergistically protect against liver injury in ovariectomized rats.
2019 Nov Eur J Pharmacol Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
2019 Rev Med Liege [How I manage a patient with type 2 diabetes not well controlled with a metformin plus gliptin combination].
2019 Sep Diabetes Obes Metab Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
2019 Biol Pharm Bull Diurnal Variation of Sitagliptin-Induced Pharmacological Effects in C57BL6J Mice.
2019 Aug Diabetes Obes Metab Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetes.
2019 Aug BMJ Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
2019 Sep J Agric Food Chem In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptide VPYPQ and Its Controlled Release from Casein by Enzymatic Hydrolysis.
2019 Aug Diabet Med Use of glucose-lowering drugs in Hungary between 2008 and 2017: the increasing use of novel glucose-lowering drug groups.
2019 Aug Br J Clin Pharmacol Pharmacokinetic-Pharmacodynamic (Dipeptidyl Peptidase-4 Inhibition) Model to Support Dose Rationale in Diabetes Patients, Including Those with Renal Impairment, for the Once-Weekly Administered Omarigliptin.
2019 Aug BMJ Case Rep DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis.
2019 Biochem Pharmacol Modulation of Sirt1NF-κB interaction of evogliptin is attributed to inhibition of vascular inflammatory response leading to attenuation of atherosclerotic plaque formation.
2019 Aug Clin Transl Sci Odds of Acute Kidney Injury in Patients Receiving Dipeptidyl Peptidase 4 Inhibitors: A National Cohort Study Within the Department of Veterans Affairs.
2019 Aug Cardiovasc Drugs Ther Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population.
2019 Diabetes Metab Syndr Obes QTQTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the "thorough QTQTc" study (Q-SET study).
2019 Diabetologia The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice.
2019 Nephrology (Carlton) Effect of sitagliptin on tubulointerstitial Wntβ-catenin signalling in diabetic nephropathy.
2019 Diabetes Care Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial.
2019 Oct Life Sci The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes.
2019 Aug J Comput Biol Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4.
2019 Aug Eur J Drug Metab Pharmaco... DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment.
2019 Aug Diabetes Obes Metab Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials.
2019 Aug Curr Med Res Opin Treatment preference for weekly versus daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: outcomes from the TRINITY trial.
2019 Artif Cells Nanomed Biote... Saxagliptin presses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis.
2019 Diabetes Ther Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program.
2019 Jul Ann Intern Med Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.
2019 Int Immunopharmacol CD26 in autoimmune diseases: The other side of "moonlight protein".